Pharmaceuticals

Fighting Diseases

Latest News
August 08, 2022
Not intended for U.S. and UK Media
U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
August 04, 2022
Second quarter of 2022
Bayer: Strong growth, outlook raised
July 14, 2022
Not intended for U.S. and UK Media
Bayer to sell men’s health product Nebido™ to Grünenthal